Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Korro Bio, Inc.KRRO · Entity 6388 | Director | June 10, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Korro Bio, Inc.
Report date June 10, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.59 · Expires 2036-06-09 | Direct | 14,677 |
Reported balance
After 2026-06-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 14,677 · Balance 14,677 F1: The shares subject to the option vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to continued service as a non-employee director through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to continued service as a non-employee director through the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 11, 2026 22:07 UTC | Korro Bio, Inc. KRRO · Entity 6388 | GrantStock Option (Right to Buy) · Derivative | 14,677 | $0.00 Strike: $10.59 | $0.00 |
DisclosureSEC source: 0001193125-26-268012 · ownership.xml · derivative · entry 1 Meyers Rachel · CIK 0002001472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,677 Underlying: Common Stock · 14,677 shares Expires 2036-06-09 F1 · derivative.exercise_date: The shares subject to the option vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to continued service as a non-employee director through the applicable vesting date. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 20:32 UTC | Korro Bio, Inc. KRRO · Entity 6388 | GrantStock Option (Right to Buy) · Derivative | 6,010 | $0.00 Strike: $14.87 | $0.00 |
DisclosureSEC source: 0000950170-25-085480 · ownership.xml · derivative · entry 1 Meyers Rachel · CIK 0002001472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,010 Underlying: Common Stock · 6,010 shares Expires 2035-06-10 F1 · derivative.exercise_date: The shares subject to the option vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to continued service as a non-employee director through the applicable vesting date. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 21:22 UTC | Korro Bio, Inc. KRRO · Entity 6388 | GrantStock Option (Right to Buy) · Derivative | 5,190 | $0.00 Strike: $42.19 | $0.00 |
DisclosureSEC source: 0000950170-24-072562 · ownership.xml · derivative · entry 1 Meyers Rachel · CIK 0002001472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,190 Underlying: Common Stock · 5,190 shares Expires 2034-06-10 F1 · derivative.exercise_date: The shares subject to the option vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to continued service as a non-employee director through the applicable vesting date. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:55 UTC | Korro Bio, Inc. KRRO · Entity 6388 | GrantStock Option (Right to Buy) · Derivative | 12,551 | $0.00 Strike: $37.50 | $0.00 |
DisclosureSEC source: 0000950170-23-066806 · ownership.xml · derivative · entry 1 Meyers Rachel · CIK 0002001472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,551 Underlying: Common Stock · 12,551 shares Expires 2033-11-26 F1 · derivative.exercise_date: The shares subject to the option vest in three equal annual installments commencing from November 27, 2023, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.